ChemoMetec A/S (CHEMM.CO)
DKK 483.0
(0.12%)
DKK 483.0
(0.12%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -291.99 Million DKK | 5.63% |
| 2023 | -309.41 Million DKK | -53.0% |
| 2022 | -202.23 Million DKK | -36.87% |
| 2021 | -147.75 Million DKK | -56.1% |
| 2020 | -94.65 Million DKK | -19.21% |
| 2019 | -79.4 Million DKK | -868.93% |
| 2018 | 10.32 Million DKK | 9.17% |
| 2017 | 9.45 Million DKK | 16.62% |
| 2016 | 8.11 Million DKK | 365.07% |
| 2015 | -3.06 Million DKK | 39.98% |
| 2014 | -5.09 Million DKK | 21.86% |
| 2013 | -6.52 Million DKK | -22.61% |
| 2012 | -5.32 Million DKK | -76.89% |
| 2011 | -3 Million DKK | -130.85% |
| 2010 | -1.3 Million DKK | 81.81% |
| 2009 | -7.16 Million DKK | -32.65% |
| 2008 | -5.4 Million DKK | 75.97% |
| 2007 | -22.47 Million DKK | -26.12% |
| 2006 | -17.81 Million DKK | -1962.15% |
| 2005 | -864 Thousand DKK | -452.65% |
| 2004 | 245 Thousand DKK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -226.2 Million DKK | 0.97% |
| 2024 Q4 | -291.99 Million DKK | 0.96% |
| 2024 Q1 | -228.42 Million DKK | 26.17% |
| 2024 FY | -291.99 Million DKK | 5.63% |
| 2024 Q3 | -294.81 Million DKK | -30.33% |
| 2023 FY | -309.41 Million DKK | -53.0% |
| 2023 Q1 | -218.96 Million DKK | -8.28% |
| 2023 Q4 | -309.41 Million DKK | 0.8% |
| 2023 Q2 | -216.47 Million DKK | 1.14% |
| 2023 Q3 | -311.91 Million DKK | -44.09% |
| 2022 FY | -202.23 Million DKK | -36.87% |
| 2022 Q1 | -110.59 Million DKK | 25.15% |
| 2022 Q3 | -203.14 Million DKK | -86.78% |
| 2022 Q2 | -108.75 Million DKK | 1.66% |
| 2022 Q4 | -202.23 Million DKK | 0.45% |
| 2021 Q1 | -106.88 Million DKK | -12.93% |
| 2021 Q3 | -148.6 Million DKK | -39.84% |
| 2021 Q4 | -147.75 Million DKK | 0.57% |
| 2021 FY | -147.75 Million DKK | -56.1% |
| 2021 Q2 | -106.26 Million DKK | 0.58% |
| 2020 Q1 | -288.31 Million DKK | -263.11% |
| 2020 Q2 | -288.31 Million DKK | 0.0% |
| 2020 FY | -94.65 Million DKK | -19.21% |
| 2020 Q4 | -94.65 Million DKK | 0.71% |
| 2020 Q3 | -95.32 Million DKK | 66.94% |
| 2019 Q3 | -79.4 Million DKK | -1012.01% |
| 2019 Q4 | -79.4 Million DKK | 0.0% |
| 2019 FY | -79.4 Million DKK | -868.93% |
| 2019 Q2 | 8.7 Million DKK | 2.94% |
| 2019 Q1 | 8.45 Million DKK | -18.1% |
| 2018 Q3 | 10.08 Million DKK | -41.34% |
| 2018 FY | 10.32 Million DKK | 9.17% |
| 2018 Q4 | 10.32 Million DKK | 2.42% |
| 2018 Q1 | 14.82 Million DKK | 56.77% |
| 2018 Q2 | 17.18 Million DKK | 15.89% |
| 2017 Q1 | 12.37 Million DKK | 52.53% |
| 2017 Q3 | 9.19 Million DKK | -27.25% |
| 2017 Q2 | 12.63 Million DKK | 2.13% |
| 2017 FY | 9.45 Million DKK | 16.62% |
| 2017 Q4 | 9.45 Million DKK | 2.9% |
| 2016 Q2 | 16.31 Million DKK | 2.17% |
| 2016 FY | 8.11 Million DKK | 365.07% |
| 2016 Q3 | 7.86 Million DKK | -51.78% |
| 2016 Q4 | 8.11 Million DKK | 3.11% |
| 2016 Q1 | 15.96 Million DKK | 621.76% |
| 2015 Q1 | 1.21 Million DKK | 123.77% |
| 2015 FY | -3.06 Million DKK | 39.98% |
| 2015 Q4 | -3.06 Million DKK | 18.25% |
| 2015 Q2 | 1.21 Million DKK | 0.0% |
| 2015 Q3 | -3.74 Million DKK | -408.83% |
| 2014 Q3 | -5.92 Million DKK | 12.48% |
| 2014 FY | -5.09 Million DKK | 21.86% |
| 2014 Q1 | -6.77 Million DKK | -3.79% |
| 2014 Q4 | -5.09 Million DKK | 13.97% |
| 2014 Q2 | -6.77 Million DKK | 0.0% |
| 2013 Q1 | -8.48 Million DKK | -59.52% |
| 2013 Q2 | -9.33 Million DKK | -9.97% |
| 2013 Q3 | -7.31 Million DKK | 21.68% |
| 2013 Q4 | -6.52 Million DKK | 10.75% |
| 2013 FY | -6.52 Million DKK | -22.61% |
| 2012 Q4 | -5.32 Million DKK | -300.0% |
| 2012 Q1 | -752 Thousand DKK | 75.0% |
| 2012 Q3 | -1.33 Million DKK | 82.01% |
| 2012 Q2 | -7.39 Million DKK | -883.11% |
| 2012 FY | -5.32 Million DKK | -76.89% |
| 2011 FY | -3 Million DKK | -130.85% |
| 2011 Q4 | -3 Million DKK | -300.0% |
| 2011 Q2 | -5.17 Million DKK | -1487.11% |
| 2011 Q1 | -325.75 Thousand DKK | 75.0% |
| 2011 Q3 | -752 Thousand DKK | 85.45% |
| 2010 Q3 | -325.75 Thousand DKK | 81.81% |
| 2010 Q4 | -1.3 Million DKK | -300.0% |
| 2010 FY | -1.3 Million DKK | 81.81% |
| 2010 Q1 | -1.79 Million DKK | 0.0% |
| 2010 Q2 | -1.79 Million DKK | 0.0% |
| 2009 Q2 | -1.35 Million DKK | 0.0% |
| 2009 Q4 | -1.79 Million DKK | 0.0% |
| 2009 FY | -7.16 Million DKK | -32.65% |
| 2009 Q1 | -1.35 Million DKK | 0.0% |
| 2009 Q3 | -1.79 Million DKK | -32.65% |
| 2008 Q4 | -1.35 Million DKK | 0.0% |
| 2008 Q3 | -1.35 Million DKK | 75.97% |
| 2008 Q2 | -5.61 Million DKK | 0.0% |
| 2008 Q1 | -5.61 Million DKK | 0.0% |
| 2008 FY | -5.4 Million DKK | 75.97% |
| 2007 Q4 | -5.61 Million DKK | 0.0% |
| 2007 Q2 | -4.45 Million DKK | 0.0% |
| 2007 Q3 | -5.61 Million DKK | -26.12% |
| 2007 Q1 | -4.45 Million DKK | 0.0% |
| 2007 FY | -22.47 Million DKK | -26.12% |
| 2006 Q1 | -216 Thousand DKK | 0.0% |
| 2006 Q2 | -216 Thousand DKK | 0.0% |
| 2006 Q3 | -4.45 Million DKK | -1962.15% |
| 2006 FY | -17.81 Million DKK | -1962.15% |
| 2006 Q4 | -4.45 Million DKK | 0.0% |
| 2005 Q4 | -216 Thousand DKK | 0.0% |
| 2005 Q3 | -216 Thousand DKK | -452.65% |
| 2005 Q2 | 61.25 Thousand DKK | 0.0% |
| 2005 FY | -864 Thousand DKK | -452.65% |
| 2005 Q1 | 61.25 Thousand DKK | 0.0% |
| 2004 FY | 245 Thousand DKK | 0.0% |
| 2004 Q3 | 61.25 Thousand DKK | 0.0% |
| 2004 Q4 | 61.25 Thousand DKK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Ambu A/S | 427 Million DKK | 168.382% |
| Demant A/S | 13.31 Billion DKK | 102.193% |
| GN Store Nord A/S | 11.33 Billion DKK | 102.576% |
| Scandinavian Medical Solutions A/S | 20.68 Million DKK | 1511.587% |
| ViroGates A/S | -10.72 Million DKK | -2622.019% |